TSX and Dow climb as SpaceX and AMD fall, Eli Lilly jumps on weight-loss drug demand, gold surges, oil slips and Bitcoin edges higher.
loss drug demand, gold surges, oil slips and Bitcoin edges higher.
TSX and Dow climb as SpaceX and AMD fall, Eli Lilly jumps on weight-loss drug demand, gold surges, oil slips and Bitcoin edges higher.

Markets are broadly higher today as investors push back into equities, helped by easing inflation fears and optimism that a deal to reopen the Strait of Hormuz may be near. The TSX is up 1.47%, while the TSX Venture Index is higher by 2.27%, showing broad strength across Canadian markets. In the U.S., the Dow is up 0.85% and the Nasdaq is higher by 0.62%, while London’s FTSE 100 is also modestly positive.

The macro backdrop remains active. Oil is slightly lower despite ongoing volatility tied to the Middle East, while gold is surging more than 3% as traders maintain defensive exposure. Copper is also higher, pointing to stronger industrial demand, while natural gas is weaker. Bitcoin is up modestly in Canadian-dollar terms as crypto stabilizes alongside the broader risk rally.

Market numbers

TSX: Up (+1.47%) 36,329.56

TSXV: Up (+2.27%) 919.32

DOW: Up (+0.85%) 54,692.3

NASDAQ: Up (+0.62%) 29,889.2

FTSE 100: Up (+0.18%) 10,910.09

In the headlines

  • SpaceX drops after first earnings call disappoints: SpaceX (NDAQ:SPCX), the aerospace, satellite, and launch company led by Elon Musk, fell after its first earnings call as a public company. Investors appeared encouraged by the core launch business but concerned by the company’s AI spending, mobile-service ambitions, and execution risk.
  • AMD slumps despite Q2 double beat: Advanced Micro Devices (TSX:AMD), the semiconductor company focused on CPUs, GPUs, and AI accelerators, dropped despite beating second-quarter expectations. Traders blamed weakness tied to SpaceX and broader concerns about AI infrastructure spending expectations.
  • Eli Lilly rallies on weight-loss drug demand: Eli Lilly (NYSE:LLY), the pharmaceutical company behind major obesity and diabetes treatments, surged as strong demand for weight-loss drugs boosted investor confidence. The move comes as Wall Street continues rotating into healthcare names while parts of the technology trade face turbulence.

Currencies

USD: Up (+0.17%) $0.7117

GBP: Up (+0.02%) $0.5283

EUR: Up (+0.03%) $0.61688

JPY: Down (‑0.01%) ¥112.180

AUD: Up (+0.05%) $1.0090

Bitcoin (BTC/CAD): Up (+0.15%) 90,313.5

(Conversion to C$1)

Commodities

Copper: Up (+0.73%) 6.73767

Gold: Up (+3.05%) 4,201.74

WTI: Down (‑0.15%) 74.25

Natural Gas: Down (‑0.33%) 2.689

To stay up-to-date on all of your market news head to Stockhouse.com.

Join the discussion: Find out what everybody’s saying about SpaceX and AMD on August 5th, 2026, on Stockhouse’s stock forums and message boards.


More From The Market Online

Copper junior inks deal with industry giant

Kobrea (CSE:KBX) signs an exploration agreement with BHP Metals Exploration, a division of the world's largest copper producer.

Chorus Aviation stock flying high on Q2 2026 financial results

Chorus Aviation (TSX:CHR) reported Q2 2026 net income of C$13.8 million, while adjusted net income rose...

StockTalk | Gold Report: Canadian miners crushing it in the field

Stockhouse's weekly gold report brings you top stories about mining stocks vying for a spot on your watchlist.

Capstone Copper is a 10-bagger: Why the stock could climb from here

Pulling back the curtain on Capstone Copper, a global producer whose 10-bagger returns shouldn't overshadow its substantial upside.